• Home
  • Find a Pharmacy
  • Health News
  • Medications
  • Conditions
  • RxCoupons
  • Pharmacy Solutions
RxWiki - Home
Find a Pharmacy Health News Medications Conditions RxCoupons Pharmacy Solutions

Health News

FDA Approves Drug for Acute Coronary Syndromes
The U.S. Food and Drug Administration today approved the blood-thinning drug Brilinta ( ticagrelor ) to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS).

REFINE

  • medications
      • (-) Remove Brilinta filter Brilinta
  • conditions
      • Cardiovascular (1) Apply Cardiovascular filter
        • Atherosclerosis (1) Apply Atherosclerosis filter
        • Heart Attack (1) Apply Heart Attack filter
        • High Cholesterol (1) Apply High Cholesterol filter
All information on this site is provided "as-is" for informational purposes only and is not a substitute for medical advice or treatment. You should consult with a medical professional if you have any questions about your health. The use of any information on this site is solely at your own risk.
  • Find a Pharmacy
  • Health News
  • Medications
  • Conditions
  • RxCoupons
  • Mobile App
  • Pharmacy Solutions
  • Terms and Conditions
  • Privacy Policy
  • Contact
  • Home
    Facebook
  • Home
    Google Plus
  • Home
    Twitter
© 2020 Digital Pharmacist Inc.